Cleared Special

K102812 - GAMMA-BSM

Also marketed or referenced as:
BETA-BSM EQUIVABONE

K102812 is an FDA 510(k) clearance for GAMMA-BSM, manufactured by Etex Corporation. The device is a Class 2 Dental device with product code LYC cleared through the Special 510(k) pathway after a 66-day FDA review.

K102812 · Etex Corporation · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2010
Decision
66d
Days
Class 2
Risk

K102812 is an FDA 510(k) clearance for the GAMMA-BSM. Classified as Bone Grafting Material, Synthetic (product code LYC), Class II - Special Controls.

Submitted by Etex Corporation (Cambridge, US). The FDA issued a Cleared decision on December 3, 2010 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Etex Corporation devices

FDA 510(k) Submission Details - K102812

510(k) Number K102812 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2010
Decision Date December 03, 2010
Days to Decision 66 days
Submission Type Special
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 127d · This submission: 66d
Pathway characteristics
Modification to existing cleared device.

LYC Device Classification - Class 2, Special Controls

Product Code LYC Bone Grafting Material, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - LYC Bone Grafting Material, Synthetic

All 73
Devices cleared under the same product code (LYC) and FDA review panel - the closest regulatory comparables to K102812.
MASTERGRAFT PUTTY
K140374 · Medtronic Sofamor Danek USA, Inc. · Jun 2014
BONE PLUS BCP EAGLE EYE
K122240 · Megagen Implant Co., Ltd. · Aug 2012
NOVABONE DENTAL MORSELS - BIOACTIVE SYNTHETIC BONE GRAFT
K112428 · Novabone Products, LLC · Dec 2011
VITOMATRIX
K091618 · Orthovita, Inc. · Sep 2010
BONE PLUS BCP
K090950 · Megagen Implant Co., Ltd. · Jul 2010
HEALOS DENTAL BONE GRAFT SUBSTITUTE (ALSO CALLED HEALOS OR HEALOS II) MODEL 6008, 6025
K093390 · Depuy Spine, Inc. · May 2010